Beautiful work from NSMC intern, Krishna Agarwal
The NEJM also did make a nice VA, in their own style
This week, we will discuss the first iteration of KDIGO’s 2025 guidelines on ADPKD. These guidelines are a result of a decade of global collaboration between physicians, researchers, advocates, and patients. The guidelines incorporate ADPKD-specific care as well as many general CKD management practice points.
This week, we will celebrate in advance World Kidney Day by discussing the results of OBInutuzumab in active lupus nephritis. The LUNAR trial (rituximab versus placebo) was “almost” positive, but not quite there. Would Obi overpower its cousin ritux? ✨
This week, we will continue with February’s aldosterone leitmotif: do mineralocorticoid receptor antagonists (MRAs) truly blind the diagnostic in unilateral hypraldosteronism? Is this the article the mythbuster? Draw your own conclusions
This week, we will discuss the origins of primary hyperaldosteronism in normotensive patients. Could this undetected anomaly be the cause of idiopathic hypertension and CKD?
Beautiful work from NSMC intern, Krishna Agarwal
The NEJM also did make a nice VA, in their own style
The trial is from cJASN, so we do have a visual abstract from Pablo Garcia, in the cJASN style
And Omar as well created another visual abstract, in his own inimitable style
This page discusses the common questions transplant professionals as well as transplant patients may have with COVID-19. We have few facts and little evidence, and those are laid out below. Locally, the decisions being taken depend on local resources, logistics and other factors, and hence local practice may appropriately vary.
COVID-19, the disease caused by SARS-CoV-2, has rapidly become a global pandemic. This review aims to complement the other NephJC pages with a focus on how children with kidney disease are impacted by this pandemic. Our aim is to review what we know about COVID-19 as it pertains to kidney disease in kids.
As with all the other pages on COVID-19 here on NephJC, this page on AKI & the discussion are not meant to be treatment recommendations based on sound evidence. Our aim on this page is to merely discuss the science of what we know, and some of the biology and mechanisms as well as practical management aspects.
It is hard to do a visual abstract for guidelines.
But nothing’s too hard for NSMC graduate and now faculty, Krithika Mohan aka @krithicism
Confused about how PEXIVAS reversed MEPEX? Maybe this infographic will help.
Nice work by NSM intern Namrata Parikh.
Krithika Mohan came up big this with this week’s visual abstract
Vicki Sandys put together the visual abstract for this week’s NephJC
Wow. Krystahl Andujar saved our bacon with a last minute visual abstract.
Visual abstract from Topf
CJASN had a sterling visual abstract from Michelle Rheault. Here it is